The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Takeda Pharmaceutical Co's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Takeda Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Takeda Pharmaceutical Co was 2.54. The lowest was 0.70. And the median was 1.43.
TSE:4502's Dividend Payout Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.375 * Ranked among companies with meaningful Dividend Payout Ratio only.
During the past 13 years, the highest Trailing Annual Dividend Yield of Takeda Pharmaceutical Co was 6.17%. The lowest was 2.71%. And the median was 4.39%.
During the past 12 months, Takeda Pharmaceutical Co's average Dividends Per Share Growth Rate was 2.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 3.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 2.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 0.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Takeda Pharmaceutical Co was 26.60% per year. The lowest was 0.00% per year. And the median was 0.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Takeda Pharmaceutical Co (TSE:4502) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Takeda Pharmaceutical Co Dividend Payout Ratio Related Terms
Takeda Pharmaceutical Co Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Takeda Pharmaceutical Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co Dividend Payout Ratio Chart
TSE:4502 vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's Dividend Payout Ratio falls into.
Takeda Pharmaceutical Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Takeda Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co (TSE:4502) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Takeda Pharmaceutical Co and its competitors. Over the past decade, Takeda Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.70 to 2.54. According to the industry distribution chart, Takeda Pharmaceutical Co ranks #999999 out of 444 companies in the Drug Manufacturers industry.
Is Takeda Pharmaceutical Co's Dividend Payout Ratio too high?
Takeda Pharmaceutical Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 2.54. Based on the distribution chart, Takeda Pharmaceutical Co ranks #999999 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Takeda Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Takeda Pharmaceutical Co ranks #999999 out of 444 companies for Dividend Payout Ratio. This places Takeda Pharmaceutical Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Takeda Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.70 to 2.54 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Takeda Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Takeda Pharmaceutical Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,534.46, compared to a current price of 円5,359.00 — trading 18.2% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Takeda Pharmaceutical Co's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円5,359.00 is trading 18.2% above its estimated GF Value™ of 円4,534.46.
GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4502:
Dividend Payout Ratio: 0.00
GF Value™: 円4,534.46 vs. price of 円5,359.00 (18.2% above fair value)
No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
65GF Score
Get the complete analysis for TSE:4502
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4502 has been successfully added to your 
